Hospitals & Healthcare Pressreleases

This section covers the managerial aspects in the Healthcare industry.

ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan

Wednesday, September 28, 2016
Bussinesswire

CAMBRIDGE MassBUSINESS WIRE ARIAD Pharmaceuticals Inc NASDAQ ARIA today announced that its partner Otsuka Pharmaceutical Co Ltd Otsuka has received approval from the Japanese Pharmaceuticals and Medical Devices Agency PMDA for Iclusig ponatinib for the treatment of ..

Vizient, Inc. Launches Ediom, a Cognitive Computing and Data Science Company

Wednesday, September 28, 2016
Bussinesswire

IRVING TexasBUSINESS WIRE Vizient Inc today announced the formation of Ediom LLC a cognitive computing and data science company solely focused on the needs of health care Vizient formed this new company with Anita Pramoda founder of Owned Outcomes Inc and former Chi..

Cisco Powers vRad Live Video Diagnostics Solution Site to Eliminate Geographic Boundaries for Breast Imaging, Improve Patient Care with Face-to-Face Collaboration

Wednesday, September 28, 2016
Bussinesswire

MINNEAPOLISBUSINESS WIRE vRad Virtual Radiologic a MEDNAX company NYSEMD and the leading national teleradiology services and telemedicine company announced that it has implemented its first breast imaging Live Video Diagnostics solution site at the Center for Womens Imagin..

iGetBetter Provides Care Plans for CMS-mandated CJR Bundled Payment Program

Wednesday, September 28, 2016
Bussinesswire

SUDBURYBUSINESS WIRE iGetBetter Inc a supplier of mobile digital health solutions that provide remote outpatient engagement for better outcomes for acute episodes of care as well as chronic care and long term population health management announced today the addition of ort..

Boehringer Ingelheim boosts immune-oncology pipeline through collaboration with ViraTherapeutics

Wednesday, September 28, 2016
PR Newswire

RIDGEFIELD Conn Sept 28 2016 PRNewswire Boehringer Ingelheim and ViraTherapeutics today announced a longterm collaboration to jointly develop a next generation oncolytic virus therapy platform and to investigate ViraTherapeutics lead candidate VSVGP Vesicular Stomatitis Virus VSV glycoprotein GP a..

Bayer to Showcase Latest Oncology Research at ESMO 2016 Congress

Wednesday, September 28, 2016
PR Newswire

WHIPPANY NJ Sept28 2016 PRNewswire Bayer announced today that the latest research across its growing oncology portfolio will be presented at the European Society of Medical Oncology ESMO 2016 Congress taking place on October 711 in Copenhagen Denmark The data span a variety of difficulttotreat can..

GenVec To Present At 2016 Cell & Gene Meeting On The Mesa

Wednesday, September 28, 2016
PR Newswire

GAITHERSBURG Md Sept 28 2016 PRNewswire GenVec Inc NASDAQ GNVC a clinicalstage gene delivery company announced that Douglas E Brough PhD the companys chief scientific officer will present Exploring the AdenoVerse Platform for New Advanced Cell and Gene Therapiesa brief review of GenVecs technology..

Genomic Health Reinforces Global Leadership in Genomic-based Diagnostics with Presentation of Nine Personalized Medicine Studies Conducted in Six Countries at ESMO 2016 Congress

Wednesday, September 28, 2016
PR Newswire

REDWOOD CITY Calif Sept 28 2016 PRNewswire Genomic Health Inc Nasdaq GHDX today announced that the company will present results from nine studies at the European Society for Medical Oncology ESMO 2016 Congress which will take place October 711 at the Bella Center in Copenhagen Denmark The results ..

Medicines360 and Population Services International Announce New Partnership to Expand Access to Hormonal IUDs to Women in Africa

Wednesday, September 28, 2016
PR Newswire

SAN FRANCISCOand WASHINGTON Sept 28 2016 PRNewswire Medicines360 a global nonprofit pharmaceutical company and Population Services International PSI a leading global health organization working in reproductive health announced today an agreement to expand access to Medicines360s hormonal intrauter..

New Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement Efficiency

Wednesday, September 28, 2016
PR Newswire

BOCA RATON Florida September 28 2016 PRNewswire Vycor Medical Inc Vycor OTCQBVYCO reports that a new peerreviewed study published in BioMed Research International shows improvements in visual search following the use of NovaVisions NeuroEyeCoach The threecentre study was conducted by the School ..

Neurim Pharmaceuticals Announces First Patients\' Enrollments in ReCOGNITION - Phase II Clinical Trial of Piromelatine for Mild Alzheimer\'s Disease

Wednesday, September 28, 2016
PR Newswire

TEL AVIV Israel September 28 2016 PRNewswire Neurim Pharmaceuticals Neurim announced today that the first patients have been enrolled in the ReCOGNITION study of its novel drug piromelatine for Alzheimers disease AD ReCOGNITION is a Phase 2 randomized placebo controlled dose ranging study of Pi..

Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2017 on Oct. 31

Wednesday, September 28, 2016
PR Newswire

DUBLIN Ohio Sept 28 2016 PRNewswire Cardinal Health NYSE CAH plans to release firstquarter financial results for its fiscal year 2017 on Oct 31 prior to the opening of trading on the New York Stock Exchange The company will webcast a discussion of these results beginning at 830 am Eastern To ac..

Wounded Warrior Project Joins Forces with The Fighting Irish

Wednesday, September 28, 2016
PR Newswire

NOTRE DAME Ind Sept 28 2016 PRNewswireUSNewswire Along with the University of Notre Dame Wounded Warrior Project WWP hosted a workout and physical health and wellness seminar at the universitys stateoftheart facilities After a brief safety demonstration by the Notre Dame trainers and a warmup stre..

Recent Partnership Between PatientPing, VITL and State of Vermont Proven Successful, Helping Improve Care Coordination Among Vermont Residents in First Six Months

Wednesday, September 28, 2016
PR Newswire

BOSTON Sept 28 2016 PRNewswire PatientPing a health technology company that connects providers to seamlessly coordinate patient care announced today that within a few short months over 400 provider sites across New England have been notified through PatientPing that their patients have been seen a..

Novan Announces Both SB204 Phase 3 Pivotal Trials Fully Enrolled

Wednesday, September 28, 2016
PR Newswire

DURHAM NC Sept 28 2016 PRNewswire Novan Inc the Company or Novan NASDAQ NOVN today announced that the last patient has been randomized in the Companys two identically designed Phase 3 pivotal clinical trials to evaluate the efficacy and safety of topical nitric oxidereleasing product candidate SB..

U.S. and European Physicians See a Continued Need for New Osteoporosis Therapies with Improved Safety and Tolerability, and the Potential to Increase Patient Compliance

Wednesday, September 28, 2016
PR Newswire

BURLINGTON Mass Sept 28 2016 PRNewswire Decision Resources Group finds that despite numerous available therapies for osteoporosis there remains an opportunity for therapies that offer improvements in safety and tolerability as well as efficacy Key findings from the Unmet Needs and Current Treatme..

Dr. Daniel Alkon Appointed President of Neurotrope, Inc.

Wednesday, September 28, 2016
PR Newswire

NEW YORK Sept 28 2016 PRNewswire Neurotrope Inc OTCQBNTRP a company focused on developing drugs to treat neurodegenerative diseases including Alzheimers disease today announced that it has appointed its Chief Scientific Officer Dr Daniel Alkon to the additional role of President After approximat..

Shyft Launches On-Site Group Mindfulness Meditations for the Workplace

Wednesday, September 28, 2016
PR Newswire

NEWPORT BEACH Calif Sept 28 2016 PRNewswire Shyft today announced the launch of its operations in California offering its signature 30minute guided onsite meditation program to promote mindfulness and reduce stress in the workplace Developed by an experienced team of HR professionals physicians an..

Relmada Therapeutics\' Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston

Wednesday, September 28, 2016
PR Newswire

NEW YORK Sept 28 2016 PRNewswire Relmada Therapeutics Inc OTCQB RLMD a clinicalstage company developing novel therapies for the treatment of central nervous system CNS diseases today announced that Dr Richard Mangano the companys chief scientific officer will participate in a panel of thought lead..

BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication

Wednesday, September 28, 2016
PR Newswire

FREDERICK Md Sept 28 2016 PRNewswire BioElectronics Corporation OTC Pink BIEL the maker of advanced neuromodulation medical devices announced that it has submitted a paper ActiPatch Central Sensitization Therapy A Chronic Back Pain Registry Study of Pain Relief Analgesic Adverse Effects for publ..

TOP